Clinical Trial Update: An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects [Phase 2]

View source ↗

Summary

This entry summarizes the completion of a Phase 2 clinical trial assessing the efficacy, safety, and pharmacokinetics of Beloranib in obese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Beloranib (Beloranib)

Snippet

Sponsor: Zafgen, Inc. | Conditions: Obesity | Phase 2 | Status: COMPLETED